Randox Reagents Webvertorial Image CLI December 2019

Extend your lipid testing profile with Randox

Cardiovascular disease caused by atherosclerosis is the leading cause of morbidity and mortality in Western countries. Atherosclerosis involves the hardening and narrowing of vessels in the systemic system. If the build-up increases, plaque rupturing may occur which may lead to myocardial infarction.
The mission of the National Lipid Association (NLA) “is to enhance the practice of lipid management in clinical medicine” as the current lipid testing panel consists of LDL-C, HDL-C and triglycerides. These traditional tests only detect approximately 20% of all coronary artery disease patients.  Advanced lipid testing is recommended to optimise patient treatment.
Randox offer a range of niche and superior performance lipid assays including sdLDL-C and Lp(a) to extend your lipid profile.
For more information go to: https://www.randox.com/lipid-testing-panel/

Supplier: Randox Laboratories Ltd.

Mail the supplier